175
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Movement sequencing in Huntington disease

, , , , , & show all
Pages 459-471 | Received 20 Mar 2013, Accepted 11 Feb 2014, Published online: 28 Mar 2014

References

  • Agostino R, Berardelli A, Formica, A, Accornero, N, Manfredi M. 1992. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain 115(5): 1481–1495.
  • Akaike H. 1973. Information theory as an extension of the maximum likelihood principle. In Petrov BN, Csaki F, eds. Second International Symposium on Information Theory. Budapest: Akademiai Kiado. p 267–281.
  • Anderson DR. 2008. Model based inference in the life sciences: A primer on evidence. New York: Springer.
  • Andrich J, Saft C, Ostholt N, Muller T. 2007. Assessment of simple movements and progression of Huntington's disease. J Neurol Neurosurg Psychiatry 78(4):405–407.
  • Antoniades C, Xu Z, Mason S, Carpenter R, Barker, R. 2010. Huntington's disease: changes in saccades and hand-tapping over 3 years. J Neurol 257(11):1890–1898.
  • Aylward EHP, Sparks BFB, Field KMB, Yallapragada VB, Shpritz BDO, Rosenblatt, AM, et al. 2004. Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 63(1):66–72.
  • Bates DM. 2005. Fitting linear mixed models in R. R News 5: 27–30.
  • Beck A, Steer, R, Brown G. 1996. Manual for Beck Depression Inventory II (BDI- II). San Antonio, TX: Psychology Corporation.
  • Beglinger LJ, O’Rourke JF, Wang C, Langbehn, DR, Duff K, Paulsen JS. 2010. Earliest functional declines in Huntington disease. Psychiatry Res 178(2):414–418.
  • Boecker H, Dagher A, Ceballos-Baumann, AO, Passingham, RE, Samuel M, Friston KJ, et al. 1998. Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 15O PET. J Neurophysiol 79(2):1070–1080.
  • Bradshaw JL, Phillips JG, Dennis C, Mattingley JB, Andrewes D, Chiu E. 1992. Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease. J Clin Exp Neuropsychol 14(2):179–192.
  • Brotchie P, Iansek R., Horne MK. 1991. Motor function of the monkey globus pallidus. Brain 114(4):1685–1702.
  • Campodonico JR, Codori AM, Brandt J. 1996. Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation. J Neurol Neurosurg Psychiatry 61(6):621–624.
  • Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein, DC, et al. 2006. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 47(2):215–222.
  • Del Ser T, Gonzalez-Montalvo JI, Martinez-Espinosa S, Delgado-Villapalos C, Bermejo F. 1997. Estimation of premorbid intelligence in Spanish people with the Word Accentuation Test and its application to the diagnosis of dementia. Brain Cogn 33(3):343–356.
  • Doyon J. 2008.Motor sequence learning and movement disorders. Curr Opin Neurol 21(4):478–483.
  • Duff K, Paulsen, JS, Beglinger LJ, Langbehn DR, Wang C, Stout JC, et al. 2010. “Frontal” behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 22(2):196–207.
  • Elsinger CL, Harrington DL, Rao SM. 2006. From preparation to online control: reappraisal of neural circuitry mediating internally generated and externally guided actions. NeuroImage 31(3):1177–1187.
  • Farrow M, Chua P, Churchyard A, Bradshaw JL, Chiu E, Georgiou-Karistianis N. 2006. Proximity to clinical onset influences motor and cognitive performance in presymptomatic Huntington disease gene carriers. Cogn Behav Neurol 19(4):208–216.
  • Feigin A, Ghilardi, M-F, Huang C, Ma Y, Carbon M, Guttman M, et al. 2006. Preclinical Huntington's disease: compensatory brain responses during learning. Ann Neurol 59(1):53–59.
  • Garcia M, Vanhoutte P, Pages C, Besson M-J, Brouillet E, Caboche J. 2002. The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-jun N-terminal kinase/c-jun module. J Neurosc 22(6):2174–2184.
  • Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. 1995. Advance information and movement sequencing in Gilles de la Tourette's syndrome. J Neurol Neurosurg Psychiatry 58(2):184–191.
  • Georgiou N, Iansek R, Bradshaw JL, Phillips JG, Mattingley JB, Bradshaw JA. 1993. An evaluation of the role of internal cues in the pathogenesis of Parkinsonian hypokinesia. Brain 116(6):1575–1587.
  • Ghilardi MF, Silvestri G, Feigin A, Mattis P, Zgaljardic D, Moisello C, et al. 2008. Implicit and explicit aspects of sequence learning in pre-symptomatic Huntington's disease. Parkinsonism Rel Disord 14(6):457–464.
  • Giordani B, Berent S, Boivin MJ, Penney JB Jr, Lehtinen S, Markel D, et al. 1995. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol 52(1):59–64.
  • Girotti F, Marano R, Soliveri P, Geminiani G, Scigliano G. 1988. Relationship between motor and cognitive disorders in Huntington's disease. J Neurol 235(8):454–457.
  • Gladsjo JA, Heaton RK, Palmer BW, Taylor MJ, Jeste DV. 1999. Use of oral reading to estimate premorbid intellectual and neuropsychological functioning. J Int Neuropsychol Soc 5(3):247–254.
  • Harrington DL, Smith MM, Zhang Y, Carlozzi NE, Paulsen JS, Predict-HD Investigators of the Huntington Study Group. 2012. Cognitive domains that predict time to diagnosis in prodromal Huntington disease. J Neurol Neurosurg Psychiatry 83(6):612–619.
  • Hefter H, Homberg V, Lange HW, Freund H-J. 1987. Impairment of rapid movement in Huntington's disease. Brain 110(3): 585–612.
  • Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM. 2007. Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 13(3):539–543.
  • Huntington Study Group. 1996. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 11(2): 136–142.
  • Kirkwood SC, Siemers E, Hodes ME, Conneally PM, Christian JC, Foroud T. 2000. Subtle changes among presymptomatic carriers of the Huntington's disease gene. J Neurol Neurosurg Psychiatry 69(6):773–779.
  • Kirkwood SC, Siemers E, Stout JC, Hodes ME, Conneally PM, Christian JC, et al. 1999. Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers. Arch Neurol 56(5):563–568.
  • Lehéricy S, Bardinet E, Tremblay L, Van de Moortele P-F, Pochon J-B, Dormont D, et al. 2006. Motor control in basal ganglia circuits using fMRI and brain atlas approaches. Cerebr Cortex 16(2):149–161.
  • Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. 2002. Longitudinal study evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 year. Acta Neurol Scand 106(3):131–141.
  • Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. 2004. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation – a longitudinal follow-up study. J Neurol 251(8):935–942.
  • Little RJ, Rubin DB. 2002. Statistical analysis with missing data. 2nd ed. New York: John Wiley.
  • Long JD. 2012. Longitudinal data analysis for the behavioral sciences using R. Thousand Oaks, CA: Sage Publications.
  • Maroof DA, Gross, AL, Brandt, J. 2011. Modeling longitudinal change in motor and cognitive processing speed in presymptomatic Huntington's disease. J Clin Exp Neuropsychol 33(8):901–909.
  • Nelson HE, Willison J. 1991. The National Adult Reading Test (NART): Test manual. 2nd ed. Windsor, UK: NFER Nelson.
  • Paulsen JS, Hayden M, Stout JC, Langbehn DR, Aylward E, Ross CA, et al. 2006. Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 63(6):883–890.
  • Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M, et al. 2008. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 79(8):874–880.
  • Penney JB Jr, Young AB, Shoulson I, Starosta-Rubenstein S, Snodgrass SR, Sanchez-Ramos J, et al. 1990. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 5(2):93–99.
  • R Development Core Team 2010. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing.
  • Rogers MA, Bradshaw JL, Phillips JG, Chiu E, Mileshkin C, Vaddadi K. 2002. Mental rotation in unipolar major depression. J Clin Exp Neuropsychol 24(1):101–106.
  • Rowe KC, Paulsen JS, Langbehn DR, Duff K, Beglinger LJ, Wang C, et al. 2010. Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology 24(4):435–442.
  • Saft C, Andrich J, Meisel N-M, Przuntek H, Müller T. 2006. Assessment of simple movements reflects impairment in Huntington's disease. Mov Disord 21(8):1208–1212.
  • Schmidt K, Metzler P. 1992. Wortschatztest (WST). Weinheim: Beltz Verlag.
  • Smith M, Brandt J, Shadmehr R. 2000. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 403(6769):544–549.
  • Snowden JS, Craufurd D, Thompson J, Neary D. 2002. Psychomotor, executive, and memory function in preclinical Huntington's disease. J Clin Exp Neuropsychol: Off J Int Neuropsychol Soc 24(2):133–145.
  • Solomon AC, Stout JC, Weaver M, Queller S, Tomusk A, Whitlock KB, et al. 2008. Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord 23(13):1830–1836.
  • Stout JC, Paulsen JS, Queller S, Solomon AC, Whitlock KB, Campbell JC, et al. 2011. Neurocognitive signs in prodromal huntington disease. Neuropsychology 25(1):1–14.
  • Tanji J, Kurata, K. 1985. Contrasting neuronal activity in supplementary and precentral motor cortex of monkeys. I. Responses to instructions determining motor responses to forthcoming signals of different modalities. J Neurophysiol 53(1):129–141.
  • Tabrizi SJ, Scahill RI, Durr A, Roos, RA, Leavitt, BR, Jones R, et al. 2011. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 10(1):31–42.
  • Tabrizi SJ, Reilmann R, Roos RAC, Durr, A, Leavitt, B, Owen, G, et al. 2012. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11:42–53.
  • Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, et al. 2002. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 125(8):1815–1828.
  • Verbeke G, Molenberghs G. 2000. Linear mixed models for longitudinal data. New York: Springer-Verlag.
  • Witjes-Ane M-NW, Mertens B, van Vugt JPP, Bachoud-Levi A-C, van Ommen, G-JB, et al. 2007. Longitudinal evaluation of “presymptomatic” carriers of Huntington's disease. J Neuropsychiatry Clin Neurosci 19(3):310–317.
  • Yágüez L, Lange H, Hömberg V. 2006. Differential effect of Huntington's and Parkinson's diseases in programming motor sequences of varied lengths. J Neurol 253(2):186–193.
  • Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS, et al. 2011. Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B: Neuropsychiatric Genet 156(7):751–763.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.